Navigation Links
PURE Bioscience CEO to Ring NASDAQ Closing Bell
Date:7/11/2008

SAN DIEGO, July 11 /PRNewswire-FirstCall/ -- PURE Bioscience (Nasdaq: PURE) announced today that Michael L. Krall, the company's president and CEO, is scheduled to ring the closing bell at the NASDAQ Stock Exchange at 4:00 PM on Tuesday, July 15, 2008, to commemorate PURE's return to the NASDAQ stock market on April 2, 2008.

(Logo: http://www.newscom.com/cgi-bin/prnh/20060119/LATH060LOGO)

A live webcast of the closing ceremony will begin at 3:50 PM and can be viewed via The MarketSite Webcam by launching this link: http://www.nasdaq.com/about/marketsitetowervideo.asx.

Earlier this month, PURE entered into an agreement with FTA Therapeutics, LLC for the development and licensing of silver dihydrogen citrate (SDC)-based products for clinical projects for FDA-regulated dermatology, wound care and medical biofilm control products. In April, PURE announced a partnership with Rockline Industries Inc, for North American distribution of PURE's ready-to-use "Powered by SDC" disinfectant product and for the development and North American distribution of wipes products, as well as new disinfectant, sanitizer and preservative products containing the company's patented antimicrobial, silver dihydrogen citrate (SDC).

"Powered by SDC(TM)"

SDC, PURE Bioscience's flagship technology, is the first new disinfectant active to be registered by the EPA in more than 30 years, and "Powered by SDC" disinfectants combine extraordinary broad spectrum antimicrobial action with a previously unattainable safety profile. SDC is a patented, aqueous non-toxic antimicrobial, which is an electrolytically generated source of stabilized ionic silver that can serve as the basis for a broad range of products in diverse markets. PURE also manufactures and sells varying strengths of SDC concentrate as
'/>"/>

SOURCE PURE Bioscience
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
2. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
3. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
4. Ohio Ranks Best in the Midwest for Venture Capital Investment in Health Care Bioscience Industry
5. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
6. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
7. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
8. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
9. Todd R. Nelson Named Chief Executive Officer of eBioscience, Inc.
10. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
11. Pressure BioSciences, Inc. Issued First Patent in Canada
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... laureate Herbert Kroemer famously observed, referring to the ... where layers of different materials meet. In today,s ... of metal oxides are becoming increasingly prominent, with ... superconductors, ferroelectrics and multiferroics. Realizing the vast potential ...
(Date:1/15/2014)... January 15, 2014 Look inside the ... items for the lab, from fluid handling to instruments ... to ship when you order. , Preferred Solutions ... , from the L/S® model for precise flow control ...
(Date:1/15/2014)... Canada (PRWEB) January 15, 2014 This ... on nonclinical and clinical safety assessment in biosimilars. , ... path for biosimilar drug development, however the complex nature ... to quality, safety and efficacy extremely challenging. Based on ...
(Date:1/15/2014)... The Microcompetition with Foreign DNA theory explains ... these latent viruses is the Epstein Barr Virus (EBV), and ... (RA) is a chronic inflammatory disease that destroys the body’s ... RA patients have high concentrations of EBV DNA in their ...
Breaking Biology Technology:A deeper look at interfaces 2Cole-Parmer Begins 2014 with the Release of Preferred Solutions 2Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3
... ... therapy. Two years after endovascular treatment, 88 percent of women avoided amputation compared to ... ... are at risk of lower-leg amputation fare even better than men when they have minimally ...
... divas of the nanoworld. In possession of alluring properties, ... cousins. On the plus side, they can withstand ... Yoke Khin Yap, an associate professor of physics at ... in a barbecue at half of those temperatures," he ...
... , , , , , SAN ... ), a biopharmaceutical company focused on developing and commercializing novel ... Chief Executive Officer, is scheduled to present at the 28th ... 2009 at the Westin St. Francis Hotel in San Francisco, ...
Cached Biology Technology:Women More Likely Than Men to Avoid Amputation After Minimally Invasive Therapy for Blocked Leg Arteries 2Women More Likely Than Men to Avoid Amputation After Minimally Invasive Therapy for Blocked Leg Arteries 3Harnessing the divas of the nanoworld 2NeurogesX to Present at J.P. Morgan Health Care Conference 2NeurogesX to Present at J.P. Morgan Health Care Conference 3
(Date:7/9/2014)... can alleviate the symptoms of Alzheimer,s disease, ... and effectively scavenge amyloid beta peptide in ... reduced and eliminated Aβ deposition in an ... significantly improved behavioral and cognitive impairment. Dr. ... Hospital of China Medical University, China immunized ...
(Date:7/9/2014)... numerous inhabitants of the sea: tiny haptophytes of the ... naked eye, when they are in bloom in spring, ... visible on satellite images. "Together with other phytoplankton, ... the global photosynthesis output," states Prof. Dr. Georg Pohnert ... process the greenhouse gas carbon dioxide CO2 ...
(Date:7/8/2014)... future health of the world,s coral reefs and the ... the ability of one tiny symbiotic sea creature to ... algae it cooperates with. , In the first study ... discovered that coralstiny reef-forming animals that live symbiotically with ... heat stress, called "bleaching," when they keep large energy ...
Breaking Biology News(10 mins):Short circuit in the food web 2For corals adapting to climate change, it's survival of the fattest -- and most flexible 2For corals adapting to climate change, it's survival of the fattest -- and most flexible 3For corals adapting to climate change, it's survival of the fattest -- and most flexible 4
... of the Spanish Foundation for Biodiversity, the Charter Provincial Council ... R+D Centre will be studying the re-stocking of the three ... of May, June and July, respectively, in three streams of ... information needed to be able to manage the species and ...
... This release is available in German . ... Germany, the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) is to ... by the appropriate Grants Committee in Bonn. The new institutions ... half years, during which time they will receive total funding ...
... the Walter and Eliza Hall Institute in Melbourne, Australia, ... the UK,s peak academy promoting excellence in science. ... to the Royal Society in 2011, including four Australians. ... process on the basis of excellence in science. ...
Cached Biology News:A study will enable the survival and growth of the 3 development phases of the European eel 2DFG establishes 18 new research training groups 2DFG establishes 18 new research training groups 3DFG establishes 18 new research training groups 4DFG establishes 18 new research training groups 5DFG establishes 18 new research training groups 6DFG establishes 18 new research training groups 7DFG establishes 18 new research training groups 8DFG establishes 18 new research training groups 9DFG establishes 18 new research training groups 10Top Australian malaria researcher elected Fellow of the Royal Society 2Top Australian malaria researcher elected Fellow of the Royal Society 3
... the needs of the biopharmaceutical ... supports fast cell growth rates ... maintaining high cell viability and ... the Baculovirus Expression Vector System ...
Mol wt: average mol wt12,360.96 Da by calculation...
A set of five proteins which can be used to calibrate a Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) or Electrospray Ionization (ESI) mass spectrometer....
Originally developed for the culture of Drosophila; suitable for culture of other dipteran cell lines. Powder, Insect cell culture tested...
Biology Products: